Vitality Watch

Dossier rss preclinical 29-sep-2026
Animal model, organoid, or cell-culture result — not yet human

α‐Synuclein Promotes Atherosclerosis by Impairing Macrophage Autophagic Flux

Key claim: α-Synuclein promotes atherosclerosis by impairing autophagic flux in macrophages.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

α-Synuclein has been treated as a brain-specific neurodegeneration protein, so a mechanism in which it impairs macrophage autophagy and promotes atherosclerosis forces the proteostasis-failure story to cross hallmark lines into vascular biology. If the finding holds, it widens the macrophage-autophagy node already implicated in plaque biology to include aggregation-prone proteins beyond classic lipid/damage DAMPs, and raises the question of whether cardiovascular risk tracks with peripheral α-synuclein biology. The evidence is a sparse preclinical citation without human outcome data, so the biology is a hypothesis-level cross-connection rather than an atherosclerosis-pathogenesis update.

Source

Link

Briefing card

α‐Synuclein Promotes Atherosclerosis by Impairing Macrophage Autophagic Flux
Stage: preclinical · rss · 29-sep-2026

Applies to researchers mapping α-synuclein biology — this finding places the protein inside atherosclerotic macrophage autophagy, not only in neurons.

α-Synuclein promotes atherosclerosis by impairing autophagic flux in macrophages.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70713?af=R

build build 880 · 2bcef25 · 2026-11-18